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The bishydrocotarnines 2a and 2b1)' **) were converted into the urethanes 9a and 9b and into the carba-
mates 10a and 10b, which in turn were split to yield the sec. amines 1 la and 1 lb. Cyclisation with diethyl 
oxalate led to the diketopiperazines 12a and 12b. Contrary to 9b, compound 9a was resolved into enan-
tiomers on a cellulose carbamate column. This indicates that 9a is the D, L- and 9b is the meso form. N M R 
spectra of 12a and 12b led to an analogous conclusion. 
Bishydrocotarnine - Stereochemische Gesichtspunkte 
Die Bishydrocotarnine 2a und 2b1) werden in die Urethane 9a und 9b bzw. in die Carbamate 10a und 10b 
umgewandelt. Spaltung von 10a bzw. 10b in die sek. Amine 1 la und 1 lb und deren Cyclisierung führen 
zu den Diketopiperazinen 12a und 12b. 9a ließ sich im Gegensatz zu 9b an einer Cellulosecarbamat-Säule 
in Enantiomere spalten. Danach ist 9a die D, L-, 9b die meso-Form. NMR-Spektren von 12a und 12b füh-
ren zu derselben Schlußfolgerung. 
In 1911, Freund and Kupfer^ described the formation of two isomeric bishydrocotarnines 2 by reduc-
tive dimerisation of cotarnine (1). This reduction occurs when a bulky Grignard reagent obtained from 
1,2-dibromoethane was used, whilst small monofunctional Grignard reagents added smoothly to the car-
benium-iminium-ion in 1. Freund et al.1) separated the isomers of 2 and elucidated their structures unequi-
vocally. The authors recognized that these symmetric molecules should exist as two enantiomers and as 
one meso form and tried to resolve one of the 2-isomers by formation of diastereomeric salts. When all 
their efforts failed they concluded that both isomers should be meso forms which arise by combination of 
two eis- and of two trans-forms of the tetrahydropyridine-moiety1). In this context "eis" and "trans" refer 
to H at C - l (C-l') and C H 3 at the adjoining N-atoms (see1), page 16). 
According to Dreiding models, Freund % meso forms!) nowadays might be regarded 
as two conformers, the one with a bi-equatorial bond between C - l and C - l ' and axial 
methyl-groups, the other one with equatorial CH3-groups and a bi-axial linkage of C - l 
+ ) Dedicated to Prof. Dr. Maurice Shamma, The Pennsylvania State University, on the occasion of his 
60th anniversary. 
**) Index a: racemates; index b: meso forms. 
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with C - l ' . When Freund and Kupferx) heated the minor isomer of 2 to temp, exceeding 
the m. p., it was converted to the major isomer. This was explained as a thermal cis-
Jrans-rearrangement. We became aware of Freunds isomers when we tried to cleave a-
narcotine (3) regioselectively by various bases to get narcotoline (4). 3 was recovered 
nearly quantitatively, 2a and 2b arose as minor products besides 1 and opianic acid 
(6-formyl-2,3-dimethoxybenzoic acid). As already stated by Freundl\ 2a and 2b have 
the same m. p. (163°), the mixed m. p. is depressed significantly. The isomers are easily 
differentiated by tic on alumina (ethyl acetate): 2a exhibits a low, 2b a high rf-value. 
R R 
2a CH3 2b CH3 
9a CO-OC2H5 9b C0-0C2H5 
10a CO-OCH2-CCl3 10b CO-OCH2-CCl3 
11a H 11b H 
12a 12b 
Contrary to Freundl) we found that both isomers are mutually converted to each 
other by melting them. Up to 150° we did not observe isomerisation in solution (d5-ni-
trobenzene, NMR-control); heating 2a or 2b to 190° (tetralin) led to mutual conver-
sion. For differentiation between the possibilities of rotamers or products obtained 
from bond breaking and recombination, we synthesized the corresponding 8,8'-desme-
thoxybishydrocotarnines (lj'-bishydrohydrastinines 52)) as a mixture of stereoiso-
mers with very similar rf-values. When we melted equal quantities of 5 and 2(1:1 mix-
ture of 2a and 2b), we obtained the "mixed" bistetrahydroisoquinoline 6 (scheme 2) be-
sides the 5-isomers, 2a and 2b (tic). The FD-mass spectrum revealed molecular ions at 
m/z 440 (2a, 2b), m/z 380 (5) and m/z 410 (6), indicating that at least in part bond 
breaking and recombination had occurred, so favouring FreuncTs assumption of a pi-
nacol type formation of 2a and 2bl\ Moreover, this experiment points towards diaste-
reoisomerism of 2a and 2b. 
2a and 2b could not be resolved on microcrystalline cellulose triacetate3), probably 
on account of insufficient solubility in suitable solvents (EtOH; CHC1 3: EtOH 1:9). 
Therefore, we decided to block the rotation around the C-l/C-l'-bond by construction 
of rigid cyclic derivatives of 2a and 2b in order to associate J (H-l/H-T) with 2a and 
2b, respectively. Formation of bisquaternary cyclic derivatives failed: heating 2a with 
1,4-dibromobutane led to the mono-quaternized compund 7. In this context it is note-
worthy that Freundl) as well as ourselves obtained the monomethylated derivative 8 
from 2a even with an excess of CH 3 I under vigorous conditions. So we adopted Drei-
ding's approach4) which he had elaborated for a similar problem, i. e. formation of the 
pertinent 2,3-diketopiperazines 12a and 12b. 
For twofold N-demethylation of 2a and 2b we slightly varied Lee's method5) for 
N-demethylation of tert. benzylamines with ethyl chloroformate (ECF) or ß,ß,ß-tri-
chloroethyl chloroformate. Heating 2a and 2b with a 5-fold molar excess ECF afford-
ed the urethanes 9a and 9b. In order to rule out an isomerisation, 9a and 9b were recon-
verted to 2a and 2b, respectively, by L i A l H 4 6 ) : no isomerisation had occurred. 
Various racemic compounds have been resolved by HPLC on cellulose triphenyl-
carbamate coated on silica gel7). This chiral stationary phase resolved 9a partially into 
enantiomers. Cellulose tris-(p-chlorophenylcarbamate)8) was found to be a more effec-
tive chiral stationary phase for 9a and base-line separation of the enantiomers was at-
tained. The basic compound, 2a, was not resolved to a detectable extent on the two cel-
lulose phenylcarbamate columns showing a very broad peak with a long tailing. Simi-
lar results have been observed in the resolution of some amines on the columns7). This 
experiment clearly indicates that 9a is the racemate, 9b is the meso form. 
The 250 MHz-^-spectra of 9a and 9b indicate the presence of at least three diffe-
rent species - rotamers? - which leads to trebling of most of the signals; the H 3 C - C H 2 -
regions are shown in fig. 1. 
Therefore, addition of (+)-Eu(facam)3 did not allow a clear-cut decision between the 
racemate and the meso form of 9. 
Whilst ethyl urethanes of type 9 can be hydrolyzed only under drastic conditions9), 
ß,ß,ß-trichloroethyl carbamates are converted to sec. amines by mild reductive cleav-
age .^ When we reacted 2a and 2b with Cl-CO-0-CH 2 -CCl 3 , the urethanes 10a and 
10b arose, which were split to the amines 1 la and 1 lb by Zn/acetic acid. Twofold ami-
dation with diethyl oxalate4) afforded the diketopiperazines 12a and 12b, respectively. 
These molecules also provide an unequivocal differentiation between the precursors 2a 
and 2b: the racemate 12a from 2a shows a sharp singlet at 5 = 5.16 ppm of H - l and 
61.5 1.0 6 1.0 
Fig. 1: H3C-CH2-multiplets of 9a and 9b 
H-1', whilst H-1 and H-1' (or vice versa) in 12b (meso form from 2b) resonate at 5.49 
and 5.66 ppm, respectively, whith J = 3.72 Hz. 
We are grateful to Prof. Dr. A. Mannschreck, Regensburg, for helpful discussions and to Mr. Kawashi-
ma for skilful experimental help in chromatographic resolution. The financial support of Deutsche For-
schungsgemeinschaft is gratefully acknowledged. 
Experimental Part 
Apparatus: mp (uncorr.): apparatus according to Dr. Tottoli; elementary analysis: Microanalytical La-
boratory (G. Wandinger) of the University of Regensburg. - IR: Beckman Acculab III. - lH-NMR: Va-
rian E M 390 (90 MHz), Bruker (250 MHz), 35°, TMS int. stand. - UV: Uvikon 810, MeOH Uvasol 
"Merck". - MS: Varian M A T CH5, excitation energy 70 eV, if not stated otherwise. 
Cotarnine base 
It was produced by modifying Bruns' method10) as follows: 4.13 g (10 mmol) narcotine base (3) in 40.0 g 
H N 0 3 (18 %) was stirred at 50° (+/-2°) until 3 had disappeared (tic, Si0 2 , MeOH). After cooling the fil-
trate was chilled with ice and basified with 40 % K O H . The precipitate formed was filtered off immediate-
ly and dried at 40° (0.1 torr): yield 2.10 g (88 %). From benzene: colourless needles, yield 1.87 g (79 %), 
mp. 132° (lit.10): 132°). - IR (KBr): 1620 cm-1 (C=C, arom.). - ! H - N M R (90 MHz, CDC1 3): 8 (ppm) = 
2.25-3.25 (m; 4H, CH 2 ) , 2.60 (s; 3H, NCH 3 ) , 4.10 (s; 3H, OCH 3 ) , 5.48 (s; 1H, C-l), 5.95 (s; 2H, 
0 -CH 2 -0 ) , 6.40 (s; 1H, arom.). 
Cotarnine chloride (1) from cotarnine base 
To an ice cold mixture of 2.0 g (8.5 mmol) crude cotarnine base and 5 ml absol. EtOH, 30 % HCl in 
EtOH was added drop by drop until the colour turned yellow (pH 5). Then 19 ml ice cold absol. acetone 

C 28 H 3 6 B r 2 N 2 0 t 6 5 6 - 4 )- Calc. C 51.2 H 5.53 N 4.3. Found C 51.4 H 5.60 N 4.3. - IR (KBr): 1630 cm-1 
(C=C arom.). - ^ - N M R (90 MHz, CDC1 3): 5 (ppm) = 1.75-2.14 (m; 4H, CH 2 ) , 2.22-2.54 (m; 1H, 
CH 2 ) , 2.38 (s; 3H, NCH 3 ) , 2.79-3.54 (m; 8H, CH 2 ) , 3.64 (s; 3H, + N C H 3 ) , 3.72, 3.74 (2 x s; 6H, 2 x 
OCH3), 3.70-4.77 (m; 5H, C - l and C - l ' , 3H of CH2-groups), 5.60, 5.66 (AB-system; 2H, 0 - C H 2 - 0 , 
J = 0.74 Hz), 5.72, 5.78 (AB-system; 2H, 0 - C H 2 - 0 , J = 0.74 Hz), 6.21, 6.27 (2 x s; 2H, arom.). 
N-Mono(S-bromo-n-butyl)-bishydrocotarninium bromide (7b) 
7b was prepared analogously in 85 % yield, m. p. 196-197°. C 2 8 H 3 6 B r 2 N 2 0 6 (656.4). Calc. C 51.2 
H 5.53 N 4.3. Found C 51.2 H 5.57 N 4.2. - IR (KBr): 1630 cm"1 (C=C, arom.). - 1 H-NMR(90 MHz, 
CDCI3): 8 (ppm) = 1.55-2.55 (m; 8H, CH 2 ) , 2.38 (s; 3H, NCH 3 ) , 2.95-3.55 (m; 6H, CH 2 ) , 3.32 (s; 3H, 
OCH3), 3.78 (s; 3H, + N C H 3 ) , 4.05-4.78 (m; 3H, C H 2 and 1H of C - l or C-l ' ) , 4.23 (s; 3H, OCH 3 ) , 5.13 
(s; 1H, C - l or C-l ' ) , 5.80-6.01 (m; 4H, 0 - C H 2 - 0 , 2 overlapping AB-systems), 6.29, 6.40 (2 x s; 2H, 
arom.). 
N-Monomethyl-bishydrocotarninium iodide (8a) 
44Vmg (1 mmol) 2a in 3 ml C H 3 I were refluxed for 2 h. - The amorphous precipitate was crystallized 
from absol. EtOH; 460 mg 8a (79 %), mp. 232-233° (lit.1): 233°). - IR (KBr): 1630 cm"1 (C=C, arom.). -
^ - N M R (250 MHz, CDC1 3): 8 (ppm) = 2.31-2.48 (m; 1H, CH 2 ) , 2.38 (s; 3H, NCH 3 ) , 2.80-3.14 (m; 
3H, CH 2 ) , 3.18-3.47 (m; 1H, CH 2 ) , 3.39 (s; 3H, + N C H 3 ) , 3.60-3.88 (m; 1H, CH 2 ) , 3.70 (s; 3H, + N C H 3 ) , 
3.74, 3.76 (2 x s, 6H, 2 x OCH 3 ) , 3.95-4.13 (m; 1H, CH 2 ) , 3.99 (d; 1H of C - l or C - l ' , J = 6.25 Hz), 
4.50-4.64 (m; 1H, CH 2 ) , 4.52 (d; 1H of C - l or C - l ' , J = 6.25 Hz), 5.63, 5.67 (AB-system; 2H, 0 - C H 2 -
O, J = 1.34 Hz), 5.74,5.79 (AB-system; 2H, 0 - C H 2 - 0 , J = 1.34 Hz), 6.23,6.29 (2 x s; 2H, arom.). 
N-Monomethyl-bishydrocotarninium iodide (8b) 
8b was prepared analogously from 440 mg 2b; 480 mg (82 %), mp. 233° (lit.1): 233°). - IR (KBr): 
1630 cm-1 (C=C, arom.). - ^ - N M R (250 MHz, CDC1 3): 5 (ppm) = 1.61-1.83 (m; 1H, CH 2 ) , 1.97-2.08 
(m; 1H, CH 2 ) , 2.29-2.45 (m; 1H, CH 2 ) , 2.40 (s; 3H, NCH 3 ) , 2.55-2.73 (m; 1H, CH 2 ) , 3.11-3.21 (m; 
2H, CH 2 ) , 3.28 (s; 3H, OCH 3 ) , 3.31 (s; 3H, + N C H 3 ) , 3.71 (s; 3H, +NCH3), 4.21 (s; 3H, OCH 3 ) , 
4.32-4.47 (m; 1H, CH 2 ) , 4.44 (s; 1H, C - l or C-l ' ) , 4.48-4.64 (m; 1H, CH 2 ) , 4.87 (s; 1H, C - l or C-l ' ) , 
5.86-5.96 (m; 4H, 0 - C H 2 - 0 , 2 overlapping AB-systems), 6.29, 6.40 (2 x s, 2H, arom.). 
Of course, the index "b" does not indicate "meso" in 7b and 8b and is used only for systematic reasons. 
5,5'-Bis-(N-ethoxycarbonyl-4-methoxy-5,6J,8-tetrahydro)-l,3-dioxolo[4,5-g]isoqm (9a and 9b) 
440 mg (1 mmol) 2a, 0.96 ml freshly distilled ethyl chloroformate and 30 mg K 2 C 0 3 were refluxed in 
10 ml absol. benzene for 48 h. After evaporation and drying i . vac. the oily residue was purified by cc 
(Si0 2, chloroform/ether 3:1-vol): 445 mg (80 %) 9a, m. p. 207°(EtOH), needles. - C 2 8 H 3 2 N 2 O 1 0 (556.6) 
Calc. C 60.4 H 5.80 N 5.0. Found C 60.4 H 5.88 N 5.0. - UV (MeOH): X max (log e) = 218 (4.5), 260 
(3.2), 283 nm (3.5). - IR (KBr): 1690 (C=0), 1630 cm-1 (C=C, arom.). - ! H - N M R (250 MHz, CDC1 3): 
8 (ppm) = 1.18-1.36 (m; 6H, 2 x C H 2 C H 3 ) , 2.65-2.83 (m; 2H, CH 2 ) , 3.15-3.66 (m; 4H, CH 2 ) , 3.35, 
3.38, 3.40 (3s; 6H, 2 x OCH 3 ) , 3.74-3.95 (m; 2H, CH 2 ) , 3.99-4.25 (m; 4H, CH 2 ) , 5.44-5.71 (6 x s; 2H, 
C - l and C-l ' ) , 5.74-5.85 (m; 4H, 2 x 0 -CH 2 -0 ) , 6.40, 6.42 (2 x s; 2H, arom.). - MS (FD): 556 M+-, 
278 (M/2) +. 
9b was prepared analogously: 290 mg (52%) 9b, m. p. 258° (EtOH), lozenge-shaped crystals. 
C 2 8 H 3 2 N 2 O 1 0 (556.6) Calc. C 60.4 H 5.80 N 5.0. Found C 60.1 H 5.83 N 5.0. - UV: X max (log e) = 
218 (4.5), 260 (3.2), 283 nm (3.5). - IR (KBr): 1680 (C=0), 1630 cm"1 (C=C, arom.). - 'H-NMR 
(250 MHz, CDC1 3): 8 (ppm) = 0.91-1.12 (overlapping t (fig. 1), 6H, 2 x - C H 2 C H 3 ) , 2.67-2.85 (m; 2H, 
CH 2 ) , 3.14-3.62 (m; 6H, CH 2 ) , 3.73-3.92 (m; 4H, CH 2 ) , 4.01,4.02,4.03 and 4.04 (4s; 6H, 2 x OCH 3 ) , 
5.49-5.75 (6 x s; 2H, C - l and C-l ' ) , 5.77-5.90 (m; 4H, 2 x 0 -CH 2 -0 ) , 6.35-6.50 (m; 2H, arom.). - MS 
(FD): 556 M + % 278 (M/2) +. 
5,5'-Bis-(N-ß,ß,ß-trichloroethoxycarbonyl-4-methoxy-5,6,7,8-tetrahydo)-l,3-dioxo 
nes (10a and 10b) 
440 mg (1 mmol) 2a, 0.3 ml (2.2 mmol) ß,ß,ß-trichloroethyl chloroformate, 30 mg (0.21 mmol) K 2 C 0 3 
and 3 ml absol. toluene were heated in an oil bath at 110° for 48 h. After evaporation and drying (60°, 
0.1 torr) crude 10a was purified by cc (Alumina Woelm N act. II, chloroform/ether l:l-vol.): 305 mg 
(40%) white foam, which could not be crystallized. C 2 8 H 2 6 C l 6 N 2 O 1 0 (763.2). Calc. C44.1 H 3.43, 
N 3.7. Found C 44.8 H 3.74 N 3.6. - UV (CH 3 CN): X max (log e) = 220 (4.2), 260 (3.1),284 nm (3.5). -
IR (KBr): 1720 (C=0), 1630 cm"1 (C=C, arom.). - ! H - N M R (CDC13): 5 (ppm) = 2.52-3.00 (m; 2H, 
CH 2 ) , 3.05-3.64 (m; 4H, CH 2 ) , 3.28, 3.30, 3.35 (3 x s; 6H, 2 x OCH 3 ) , 3.65-4.23 (m; 2H, CH 2 ) , 4.47, 
4.95 (AB-system, 2H, C H 2 , J A B = 12.0 Hz, the low field part shows additional doublet splitting, 2 J = 
7.5 Hz), 4.63 (s; 2H, CH 2 ) , 5.52-5.84 (m; 6H, 2 x 0 - C H 2 - 0 and 2H of C - l and C-l ' ) , 6.32,6.37 (2 x s; 
2H, arom.). - MS (FAB(-), 18-crown-6/pyridine): calc. M (35C1) = 760; found m/z 795; 797; 799; 801; 
803; 805; (807), corresponding to (M + CI")". 
Preparation of 10b: 440 mg (1 mmol) 2b, 0.3 ml (2.2 mmol ß,ß,ß-trichloroethyl chloroformate and 
30 mg (0.21 mmol) K 2 C 0 3 were refluxed in absol. benzene for 48 h. After evaporation and drying (see 
10a) 10b was purified by cc on silica (chloroform/ether 3:l-vol): 504 mg (66 %) yellow oil, which was 
boiled with a little ether: 340 mg (44 %) colourless crystals, mp. 251°. Recrystallization from glacial ace-
tic acid: 320 mg (42%) double pyramids, mp. 256-257°. C 2 8 H 2 6 C l 6 N 2 O 1 0 (763.2). - Calc. C44.1 
H 3.43 N 3.7. Found C 44.0 H 3.58 N 3.6. - UV (CH 3 CN): X max: (log E) = 220 (4.2), 260 (3.1), 284 nm 
(3.5). - IR (KBr): 1715 (C=0), 1630 cm"1 (C=C, arom.). - 'H-NMR (90 MHz, CDC1 3): 8 (ppm) = 
2.51-3.05 (m; 2H, CH 2 ) , 3.10-3.62 (m; 4H, CH 2 ) , 3.70-4,35 (m; 2H, CH 2 ) , 4.00, 4.03 (2 x s; 6H, 2 x 
OCH 3 ) , 4.66-4.95 (m; 2H, CH 2 ) , 5.71, 5.73 (2s; 2H, C - l and C-l ' ) 5.81-5.95 (m; 4H, 2 x 0 -CH 2 -0 ) , 
6.36,6.38,6.40(m;2H,arom.).-MS(FD,acetone):calc.M(35Cl) = 760;found760(M+-),380(M/2)+. 
5,5'-Bis-(4-methoxy-5,6,7,8-tetrahydro)-l,3-dioxolo[4,5-g-]isoquinolines (11a and lib) 
200 mg (0.26 mmol) 10b and 340 mg activated Zn-powder12>, were slightly heated in 5 ml glacial acetic 
acid, until strong evolution of H 2 occurred. Then the mixture was stirred at r. t. for 4 h, 3 ml H z O were ad-
ded. The filtrate was basified by K O H and extracted with chloroform. Drying and evaporation i. vac. led 
to an oil which was dissolved in EtOH. Addition of a few drops cone. HCl (pH 5) and scratching led to 
white needles. 
1 lb-di-HCl: 110 mg (87 %), m. p. 220-221° (decomp.). - 'H-NMR (90 MHz, CF 3 COOH): 5 (ppm) = 
2.88-4.34 (m; 8 H, CH 2 ) , 4.17 (s; 6H, 2 x OCH 3 ) , 5.34 (s; 2H, C - l and C-l ' ) , 6.00 (degenerated AB-sys-
tem; 4H, 2 x 0 -CH 2 -0 ) , 6.57 (s; 2H, arom.), 6.74-7.27 (broad s; 2H, 2 x HN), 8.27-8.83 (broad s; 2H, 
2 x HN). The solution of this salt in a little water was basified (KOH) and extracted with chloroform. 
Drying (Na 2S0 4) and evaporation produced a colourless oil, which crystallized slowly: 85 mg (79 %) 
white material, mp. 192°-193° (EtOH). C 2 2 H 2 4 N 2 0 6 (412.4). Calc. C 64.1 H 5.87 N 6.8. Found C 64.2 
H 6.01 N 6.7. - UV (CH 3 CN): A. max (log E) = 223 (4.2), 260 (3.2), 285 nm (3.6). - IR (KBr): 1625 cm"1 
(C=C, arom.). - J H - N M R (90 MHz, CDC1 3): Ö (ppm) = 2.02 (s broad; 2 H, 2 x H N , exchangeable with 
D 2 0) , 2.33-3.22 (m; 8H, CH 2 ) , 3.67 (s; 6H, 2 x OCH 3 ) , 4.33 (s; 2H, C - l and C-l ' ) , 5.72 (degenerated 
AB-system; 4H, 2 x 0 -CH 2 -0 ) , 6.20 (s; 2H, 2 x H , arom.). - MS (FAB(+), glycerol): 414 (M + 2H)+% 
413 (MH + ), 207 (M/2 + H)+, 206 (M/2) +. 
Preparation of 1 la: analogous to that of 1 lb 
1 la-di-HCl: 104 mg (82 %) white needles, mp. 220°-221° (decomp.) - ' H - N M R (90 MHz, CF 3 COOH): 
5 (ppm) = 2.80-4.28 (m; 8H, CH 2 ) , 3.98 (s; 6H, 2 x OCH 3 ) , 5.68 (s broad; 2H, C - l and C-l ' ) , 5.85 (s 
broad; 4H, 2 x 0 - C H 2 - ) , 6.43 (s; 2H, 2 x H , arom.), 7.98-8.78 (broad s; 4H, 4 HN). 
Corresponding base 11a; mp. 193°-194° (EtOH), 79 mg (73 %). C 2 2 H 2 4 N 2 0 6 (412.4) Calc. C 64.1 H 
5.87 N 6.8. Found C 63.9 H 5.91 N 6.7. - UV (CH 3 CN): X max (log e) = 229 (4.1), 260 (3.2), 285 nm 
(3.6). - IR (KBr): 1625 cm"1 (C=C, arom.). - *H-NMR (90 MHz, CDC13): 5 (ppm) = 1.80 (s broad; 2H, 
2 x H N , exchangeable with D 2 0) , 2.35 - (s; 6H, 2 x OCH 3 ) , 4.86 (s; 2H, C - l and C-l ' ) , 5.77-5.90 (m; 
4H, 2 x 0 -CH 2 -0 ) , 6.25 (s; 2H, 2 x H , arom.). - MS (FAB (+), glycerol): 413 (MH + ) , 206 (M/2) +. 
1,2,7,8,12b,12c-Hexahydro-13,14-dimethoxy-pyrazinof2,l-a:3,4-aJdi-(1,3-dioxolof4,5-gJisoquinoline)-
4,5-diones (12a and 12b) 
A suspension of 85 mg (0.2 mmol) 1 la and 150 mg (1.0 mmol) diethyl oxalate in 3.0 ml absol. EtOH was 
heated under reflux for 2.5 h. At first a clear solution is formed, later on 12a precipitated partially. After 
14 h at -20° the precipitation was complete. Washing with cold EtOH led to pure 12a (white needles) mp. 
360° (decomp., ETOH). C 2 4 H 2 2 N 2 0 8 (466.4) Calc. C 61.8 H 4.75 N 6.0. Found C 61.6; H 4.82 N 6.0. 
UV (MeOH): X max (log e) = 216 (4.6), 269 (3.5), 279 nm (3.5). - IR (KBr): 1695 (C=0), 1680 (CO), 
1625 cm-i (C=C, arom.). - *H-NMR (250 MHz, CDC13): 5 (ppm) - 2.68-2.98 (m; 6H, CH 2 ) , 3.39 (s; 
6H, 2 x OCH 3 ) , 4.85-4.97 (m; 2H, CH 2 ) , 5.16 (s; 2H, C - l and C-l ' ) , 5.82 (s; 4H, 2 x 0 -CH 2 -0 ) , 6.38 
(s; 2H, arom.). - MS (FD): = 466 M+-, 233 (M/2) +. 
12b was prepared analogously. Yield: 60 mg (63 %) small plates, mp. 273°-274° (EtOH). C 2 4 H 2 2 N 2 0 8 
(466.4) Calc. C 61.8 H 4.75 N 6.0. Found C 61.4 H 4.80 N 6.0. - UV (MeOH): X max (log e) = 218 (4.4), 
265 (3.5), 279 nm (3.6). - IR (KBr): 1680 (CO), 1620 cm"1 (C=C, arom.). - *H-NMR (250 MHz, 
CDC13): 5 (ppm) = 2.64-3.14 (m; 4H, CH 2 ) , 3.24 (s; 3H, OCH 3 ) , 3.42-3.58 (m; 2H, CH 2 ) , 3.85 (s; 3H, 
OCH 3 ), 4.10-4.28 (m; 2H, CH 2 ) , 5.50, 5.66 (2 x d, 2H, C - l and C - l ' , J = 3.7 Hz), 5.81, 5.85 (AB-sys-
tem, 2H, 0 - C H 2 - 0 , J = 1.41 Hz), 5.92,5.93 (AB-system, 2H, 0 - C H 2 - 0 , J = 1.35 Hz), 6.40,6.48 (2 x s; 
2H, 2 x H arom.). - MS (FAB(+), 18-crown-6): = 468 (M + 2H)+-, 467 (MH) + , 466 M + \ - MS (FAB(-), 
18-crown-6) = 466 M - , 465 (M-H)~. 
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